Dimienė, I. 2024. BIOLOGIC THERAPY WITH INTERLEUKIN-5 MONOCLONIC ANTIBODY MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS WITH UNDERLYING DISEASES. Pulmonology and allergology. 8, 1 (May 2024), 93-97. DOI:https://doi.org/10.37499/PIA.1431.